| For: | Singh G, Nassri A, Kim D, Zhu H, Ramzan Z. Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma. World J Gastrointest Pharmacol Ther 2017; 8(1): 60-66 [PMID: 28217375 DOI: 10.4292/wjgpt.v8.i1.60] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v8/i1/60.htm |
| Number | Citing Articles |
| 1 |
Kazushi Yamashita, Daisuke Suzuki, Katsunori Furukawa, Tsukasa Takayashiki, Satoshi Kuboki, Shigetsugu Takano, Masayuki Ohtsuka. Prognostic Value of the Combined Lymphocyte-to-Monocyte Ratio and Handgrip Strength in Patients with Resected Pancreatic Head Cancer. Cancers 2026; 18(14) doi: 10.3390/cancers18142227
|
| 2 |
M. Markus, A. Abendroth, R. Noureddine, A. Paul, S. Breitenbuecher, I. Virchow, K. W. Schmid, P. Markus, B. Schumacher, M. Wiesweg, J. Wendling, B. Mende, J. T. Siveke, M. Schuler, S. Kasper. Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy. Journal of Cancer Research and Clinical Oncology 2021; 147(2) doi: 10.1007/s00432-020-03361-0
|
| 3 |
Jaime de la Fuente, Ayush Sharma, Suresh Chari, Shounak Majumder. Peripheral blood monocyte counts are elevated in the pre-diagnostic phase of pancreatic cancer: A population based study. Pancreatology 2019; 19(8) doi: 10.1016/j.pan.2019.10.002
|
| 4 |
Shuwen Lin, Yinghua Fang, Zhikang Mo, Ye Lin, Chenggang Ji, Zhixiang Jian. Prognostic value of lymphocyte to monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patients. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01962-0
|
| 5 |
Monocyte as an Emerging Tool for Targeted Drug Delivery: A Review. Current Pharmaceutical Design 2019; 24(44) doi: 10.2174/1381612825666190102104642
|
| 6 |
Le‐ping Fang, Xiao‐yan Xu, Yu Ji, Pu‐wen Huang. The Prognostic Value of Preoperative Neutrophil‐to‐Lymphocyte Ratio in Resected Patients with Pancreatic Adenocarcinoma. World Journal of Surgery 2018; 42(11) doi: 10.1007/s00268-018-4686-7
|
| 7 |
Benjamin E. Ueberroth, Adnan Khan, Kevin J. Zhang, Philip A. Philip. Differences in Baseline Characteristics and White Blood Cell Ratios Between Racial Groups in Patients with Pancreatic Adenocarcinoma. Journal of Gastrointestinal Cancer 2021; 52(1) doi: 10.1007/s12029-020-00378-z
|
| 8 |
Jiayan Shen, Shuncong Dai, Yingshuang Huang, Xiuqin Fan, Shuhui Zhao, Zejun Wang. Correlation between related inflammation indicators and the degree of liver fibrosis in patients with chronic hepatitis B. Medicine 2025; 104(31) doi: 10.1097/MD.0000000000043545
|
| 9 |
Muhammad Shehroz Zeeshan, Zeeshan Ramzan. Current controversies and advances in the management of pancreatic adenocarcinoma. World Journal of Gastrointestinal Oncology 2021; 13(6): 472-494 doi: 10.4251/wjgo.v13.i6.472
|
| 10 |
V. Bebeshko, K. Bruslova, L. Lyashenko, T. Pushkariova, N. Tsvetkova, S. Galkina, V. Vasylenko, Zh. Yaroshenko, A. Zaitseva, L. Gonchar, S. Yatsemirskyi. ASSESSMENT OF QUALITATIVE CHANGES IN PERIPHERAL BLOOD CELLS IN CHILDREN – RESIDENTS OF RADIOLOGICALLY CONTAMINATED TERRITORIES IN THE LATE PERIOD AFTER THE ChNPP ACCIDENT. Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology 2021; 26 doi: 10.33145/2304-8336-2021-26-297-308
|
| 11 |
Wendi Li, Lianyuan Tao, Meng Lu, Dianrong Xiu. Prognostic role of platelet to lymphocyte ratio in pancreatic cancers. Medicine 2018; 97(8) doi: 10.1097/MD.0000000000009616
|
| 12 |
Ana S. Leal, Phillip Liu, Teresa Krieger-Burke, Bruce Ruggeri, Karen T. Liby. The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Models of Pancreatic Cancer. Cancers 2020; 13(1) doi: 10.3390/cancers13010096
|